
Loading, please wait...

Loading, please wait...

Childhood insulinoma represents an exceptionally rare endocrine neoplasm that frequently poses severe diagnostic and therapeutic hurdles for treating clinicians. While persistent hypoglycemia in infants predominantly stems from congenital hyperinsulinism, older children who present with neuroglycopenic symptoms require a high index of suspicion for solitary insulin-secreting neuroendocrine tumors. Because pediatric patients often display subtle or non-specific symptoms such as night sweats, behavioral disturbances, or early morning lethargy, diagnosis often suffers prolonged delays. In many cases, families endure years of recurrent medical consultations before clinicians identify true endogenous hyperinsulinism. Furthermore, conventional cross-sectional imaging frequently fails to detect small pancreatic lesions, creating substantial anxiety and delaying definitive surgical management. Recent clinical advancements demonstrate that molecular functional imaging effectively bridges this diagnostic gap, enabling targeted curative interventions.
Clinicians often face significant hurdles when evaluating recurrent hypoglycemic episodes in growing children. For instance, young children cannot always articulate symptoms of neuroglycopenia such as dizziness, confusion, or visual disturbances. Consequently, parents and healthcare providers may misinterpret early manifestations as behavioral temper tantrums, night terrors, or seizure disorders. In the reported index case, a twelve-year-old boy suffered recurrent severe hypoglycemic episodes starting at four years of age. His blood glucose levels intermittently plummeted to fifteen to twenty milligrams per deciliter, accompanied by recurrent diaphoresis and autonomic distress.
Additionally, fragmented clinical care can exacerbate diagnostic delays. Frequent family relocations or inconsistent follow-up care often lead physicians to evaluate each acute event in isolation. Therefore, practitioners must maintain vigilant clinical suspicion whenever a school-aged child presents with recurrent, unexplained hypoglycemic episodes. Clinicians must recognize that true childhood insulinoma, while rare, carries significant morbidity if left untreated. Repeated neuroglycopenia threatens developing cognitive function and exposes patients to life-threatening complications. Therefore, timely clinical identification remains essential for safeguarding long-term neurological health. By systematically investigating fasting episodes and avoiding premature psychiatric or neurological labels, pediatric teams can promptly initiate targeted biochemical testing.
Establishing an accurate biochemical diagnosis represents the crucial foundation before initiating any imaging workup. Specifically, medical teams must capture a critical blood sample during an active spontaneous hypoglycemic episode or a supervised diagnostic fast. When plasma glucose falls below fifty milligrams per deciliter, clinicians must simultaneously measure serum insulin, C-peptide, beta-hydroxybutyrate, and circulating proinsulin levels. Furthermore, clinicians must perform a toxicology screen to definitively rule out exogenous insulin or oral hypoglycemic agents.
In this patient, physicians successfully collected a critical sample when plasma glucose dropped to thirty-seven milligrams per deciliter. Laboratory assays demonstrated an inappropriately elevated serum insulin level of 105.2 microunits per milliliter and a C-peptide level of 5.48 nanograms per milliliter. These discordant values clearly confirmed endogenous hyperinsulinemic hypoglycemia, as healthy beta cells should completely suppress hormone secretion during significant hypoglycemia. Additionally, suppressed ketone production and an exaggerated glycemic response to intravenous glucagon further reinforce autonomous beta-cell hypersecretion. Because non-suppressed insulin and C-peptide levels confirm autonomous secretion, clinicians can confidently exclude alternative etiologies, such as ketotic hypoglycemia of childhood or inherited fatty acid oxidation defects. Consequently, this biochemical milestone directs the clinical team toward focused pancreatic localization.
After confirming endogenous hyperinsulinism biochemically, pediatric specialists must accurately identify the lesion's precise anatomic site within the pancreas. However, small functional neuroendocrine tumors present immense radiological localization challenges. Conventional modalities, including transabdominal ultrasonography, computed tomography, and magnetic resonance imaging, frequently yield inconclusive or discordant results. In pediatric patients, the pancreas is relatively small, and surrounding bowel gas often obscures subtle parenchymal abnormalities during ultrasound examinations.
Moreover, contrast-enhanced computed tomography carries significant ionizing radiation risks, which pediatricians strive to minimize in growing children. Magnetic resonance imaging offers superior soft-tissue resolution without radiation exposure, making it an attractive initial non-invasive choice. In the reported clinical case, abdominal magnetic resonance imaging successfully revealed a small, suspicious focal lesion within the pancreatic body. Nevertheless, magnetic resonance imaging cannot inherently differentiate between a non-functioning benign incidentaloma and an active, insulin-secreting neuroendocrine tumor. Furthermore, somatostatin receptor scintigraphy frequently proves inadequate because benign insulinomas express somatostatin receptor subtype 2 at low densities. Consequently, surgeons historically had to rely on invasive procedures like selective arterial calcium stimulation or intraoperative ultrasonography. Fortunately, targeted molecular nuclear medicine provides a safer, highly sensitive diagnostic alternative.
To overcome the spatial and functional limitations of conventional imaging, clinicians increasingly utilize glucagon-like peptide-1 receptor-targeted functional imaging. Pathological studies demonstrate that benign insulinomas express remarkably high concentrations of glucagon-like peptide-1 receptors, far exceeding normal islet cell densities. Therefore, radiolabeled exendin-4 analogues, such as gallium-68-labeled exendin-4, serve as highly specific positron emission tomography radiotracers for detecting occult insulinomas.
In this pediatric case, gallium-68 exendin-4 positron emission tomography combined with computed tomography revealed intense, focal tracer avidity in the pancreatic body lesion. Notably, the delayed maximal standardized uptake value reached 9.1, confirming intense receptor expression and precise functional concordance with the anatomic magnetic resonance findings. This molecular imaging technique delivers outstanding diagnostic accuracy, consistently outperforming both computed tomography and somatostatin receptor scans. Moreover, the scan provides absolute functional confirmation that the visible anatomic mass represents the true driver of hyperinsulinemia. Consequently, the multidisciplinary surgical team can plan a highly focused, organ-sparing intervention with immense anatomical confidence. In resource-rich settings, this functional molecular technique has rapidly become the preferred gold standard for pre-surgical localization of occult insulin-secreting lesions.
Accurate preoperative localization fundamentally transforms surgical planning and minimizes patient morbidity. Rather than subjecting pediatric patients to extensive blind pancreatectomies, surgeons can perform precise, parenchymal-sparing tumor enucleation. In this patient, the surgical team performed an open surgical enucleation of the isolated pancreatic body lesion, meticulously preserving the adjacent main pancreatic duct and healthy parenchyma. Following tumor removal, the patient's plasma glucose concentrations promptly stabilized within normal physiological limits, providing immediate intraoperative and postoperative proof of biochemical cure.
Subsequent histopathological analysis definitively corroborated the clinical and radiological diagnoses. The examination revealed a 1.7-centimeter well-differentiated pancreatic neuroendocrine tumor. Immunohistochemical evaluation classified the neoplasm as World Health Organization Grade 1, demonstrating an exceptionally low Ki-67 proliferation index of one percent. Crucially, microscopic examination confirmed negative resection margins without evidence of tumor necrosis, lymphovascular permeation, or perineural invasion. Because the tumor exhibited completely benign, low-grade histological features, the boy achieved an excellent long-term oncological and metabolic prognosis. Ultimately, this successful clinical outcome underscores how uniting anatomical magnetic resonance imaging with glucagon-like peptide-1 receptor functional positron emission tomography ensures definitive, curative surgical management for pediatric patients.
Clinicians frequently experience diagnostic delays because pediatric patients present with non-specific neuroglycopenic manifestations, such as morning lethargy, behavioral changes, emotional irritability, or suspected seizure activity. Additionally, infrequent severe episodes and frequent family relocations disrupt continuity of care. Consequently, healthcare providers often misattribute these symptoms to neurological disorders, sleep disturbances, or psychiatric illness. Only a structured diagnostic fast capturing critical hypoglycemia with simultaneous autonomous insulin and C-peptide levels enables accurate clinical diagnosis.
Glucagon-like peptide-1 receptor imaging demonstrates superior sensitivity because benign insulinomas express remarkably high densities of glucagon-like peptide-1 receptors. Conversely, benign insulinomas express somatostatin receptor subtype 2 at very low levels, causing conventional somatostatin receptor scans to miss up to fifty percent of lesions. Using gallium-68-labeled exendin-4 positron emission tomography provides intense focal tracer uptake with delayed high standardized uptake values, facilitating exceptional contrast resolution and precise functional localization even in tiny occult tumors.
Surgeons strongly prefer parenchymal-sparing tumor enucleation whenever preoperative cross-sectional and molecular imaging clearly localizes an isolated benign insulinoma away from the main pancreatic duct. This focused, organ-preserving technique successfully excises the hormonally active neoplasm while preserving surrounding endocrine and exocrine pancreatic tissue. Consequently, enucleation minimizes the long-term risks of secondary diabetes mellitus and exocrine insufficiency. Postoperative monitoring focuses on verifying immediate glycemic normalization and ensuring rapid, uneventful recovery without complications such as pancreatic fistulae.
Disclaimer: This content is for informational and educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Childhood insulinoma is a rare cause of recurrent hyperinsulinemic hypoglycemia that often eludes early diagnosis. Advanced GLP-1 receptor-targeted PET/CT imaging using 68Ga-exendin-4 complements anatomic MRI to localize occult pancreatic lesions, facilitating focused, curative surgical enucleation.
Today

A validated computable phenotype accurately identifies malnutrition in older adults in outpatient settings, achieving 95% sensitivity and predicting mortality risk.
Today

Doctors at AIIMS New Delhi have achieved a historic milestone by performing India's first open prenatal myelomeningocele repair on a 25-week unborn fetus. This landmark multidisciplinary procedure provides vital neuroprotective benefits, lowers hydrocephalus risks, and transforms maternal-fetal medicine nationwide.
Today

A randomized crossover trial reveals that daily fresh watermelon consumption significantly reduces baseline TMAO levels and favorably modulates lipid profiles, lowering triglycerides and LDL cholesterol in adults with overweight and obesity.
Today

A systematic review of over 25,000 patients reveals that surgical decompression of proximal and distal nerve compression sites significantly improves clinical outcomes in double crush syndrome, particularly for upper extremity entrapment, while highlighting key diagnostic and sequencing considerations.
Today